Venetoclax and gilteritinib combination for FLT3-mutated relapsed/refractory acute myeloid leukemia: a real-world single-center experience
Fields of Study & Subjects
Acute Myeloid Leukemia Research
Chronic Myeloid Leukemia Treatments
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Haematologica
- Publisher
- Ferrata Storti Foundation (Haematologica)
- Publication date
- 7 May 2026
- Language
- EN